Automated Immunoassay Analyzers Market Size

Automated Immunoassay Analyzers Market size was over USD 25.6 billion in 2023 and is projected to cross USD 124.9 billion by the end of 2036, growing at more than 14.1% CAGR during the forecast period i.e., between 2024-2036. In 2024, the industry size of automated immunoassay analyzers is evaluated at USD 29.2 billion.     

The automated immunoassay analyzers market is likely to witness a stable expansion, driven by the growing burden of chronic diseases and the emerging need for accurate diagnostic solutions. With healthcare providers keen on ensuring improved patient care and timely diagnosis, automated immunoassay analyzers have become vital to clinical laboratories. These analyzers return high throughput with high precision, which has made them very essential for bulk quantities of testing in hospitals and diagnostic centers. Besides, technology advancements like integrations with a digital health platform provide more ways for market expansion.

Several companies are adding momentum to the growth of automated immunoassay analyzers by announcing the launch of newer, value-added products and strategic partnerships. For example, in July 2023, Anbio Biotechnology Ltd. launched AF-100S, a compact and affordable fluorescent immunoassay solution for transforming clinical diagnostics. The release of this new product follows the sustained efforts of industry players to further advance diagnostic capabilities and meet evolving needs among healthcare providers. As a result, such innovative launches by companies are likely to continue driving growth in the automated immunoassay analyzers market.